| This article has been cited by |
| 1 | Long-term effect of a chronic low-protein multideficient diet on the heart: Hypertension and heart failure in chronically malnourished young adult rats | |
| Luiza V.P. Mendes,Sabrina R. Gonsalez,Leonardo M. Oliveira-Pinto,Amaury Pereira-Acácio,Christina M. Takiya,José H.M. Nascimento,Marcelo Einicker-Lamas,Adalberto Vieyra,Valéria M.N. Cunha,Lucienne S. Lara |
| International Journal of Cardiology.2017;238()43 |
| [DOI] |
|
| 2 | d Opioid Receptor Inverse Agonists and their In Vivo Pharmacological Effects | |
| Shigeto Hirayama,Hideaki Fujii |
| Current Topics in Medicinal Chemistry.2020;20(31)2889 |
| [DOI] |
|
| 3 | d Opioid Receptor Inverse Agonists and their In Vivo Pharmacological Effects | |
| Jitendra Kumar Sinha,Punya Sachdeva,Faizan Ahmad,Jasmine Sarkar,Raafiah Izhar,Ayesha Rahman,Shampa Ghosh |
| Current Topics in Medicinal Chemistry.2023;20(31)149 |
| [DOI] |
|
| 4 | Candesartan Improves Ischemia-Induced Impairment of the Blood–Brain Barrier In Vitro | |
| Gohei So,Shinsuke Nakagawa,Yoichi Morofuji,Takeshi Hiu,Kentaro Hayashi,Kunihiko Tanaka,Kazuhiko Suyama,Maria A. Deli,Izumi Nagata,Takayuki Matsuo,Masami Niwa |
| Cellular and Molecular Neurobiology.2015;35(4)563 |
| [DOI] |
|
| 5 | Therapeutic Properties of Highly Selective ß-blockers With or Without Additional Vasodilator Properties: Focus on Bisoprolol and Nebivolol in Patients With Cardiovascular Disease | |
| Waleed AlHabeeb,Sanaa Mrabeti,Ahmed Adel Ibrahim Abdelsalam |
| Cardiovascular Drugs and Therapy.2022;36(5)959 |
| [DOI] |
|
| 6 | Design, synthesis and biological activity of a novel ethylenediamine derivatives as H1 receptor antagonists | |
| Shiyang Zhou,Gangliang Huang,Guangying Chen |
| Bioorganic & Medicinal Chemistry.2019;27(24)115127 |
| [DOI] |
|
| 7 | Inverse Agonistic Action of 3-Iodothyronamine at the Human Trace Amine-Associated Receptor 5 | |
| Juliane Dinter,Jessica Mühlhaus,Carolin Leonie Wienchol,Chun-Xia Yi,Daniela Nürnberg,Silke Morin,Annette Grüters,Josef Köhrle,Torsten Schöneberg,Matthias Tschöp,Heiko Krude,Gunnar Kleinau,Heike Biebermann,Renping Zhou |
| PLOS ONE.2015;10(2)e0117774 |
| [DOI] |
|
| 8 | A Review of the Mechanism of Action of Drugs Used in Congestive Heart Failure in Pediatrics | |
| Rakshit K Singh,Revat J Meshram,Aakriti Tiwari |
| Cureus.2023;10(2)e0117774 |
| [DOI] |
|
| 9 | Detailed insight on ß-adrenoceptors as therapeutic targets | |
| Bharath Kumar Velmurugan,Rathinasamy Baskaran,Chih-Yang Huang |
| Biomedicine & Pharmacotherapy.2019;117(2)109039 |
| [DOI] |
|
| 10 | Cannabinoids: Potential Role in Inflammatory and Neoplastic Skin Diseases | |
| Rose Milando,Adam Friedman |
| American Journal of Clinical Dermatology.2019;20(2)167 |
| [DOI] |
|
| 11 | The melatonin receptor antagonist luzindole induces Ca2+ mobilization, reactive oxygen species generation and impairs trypsin secretion in mouse pancreatic acinar cells | |
| Matias Estaras,Fatma Z. Ameur,Vicente Roncero,Miguel Fernandez-Bermejo,Gerardo Blanco,Diego Lopez,Jose M. Mateos,Gines M. Salido,Antonio Gonzalez |
| Biochimica et Biophysica Acta (BBA) - General Subjects.2019;1863(11)129407 |
| [DOI] |
|
| 12 | Involvement of Histamine 2 Receptor in Alpha 1 Adrenoceptor Mediated Cardiac Hypertrophy and Oxidative Stress in H9c2 Cardio Myoblasts | |
| Ajay Godwin Potnuri,Lingesh Allakonda,Sherin Saheera |
| Journal of Cardiovascular Translational Research.2021;14(1)184 |
| [DOI] |
|
| 13 | GABAergic regulation of cell proliferation within the adult mouse spinal cord | |
| Lauryn E. New,Yuchio Yanagawa,Glenn A. McConkey,Jim Deuchars,Susan A. Deuchars |
| Neuropharmacology.2023;223(1)109326 |
| [DOI] |
|
| 14 | Discovery of d Opioid Receptor Full Inverse Agonists and Their Effects on Restraint Stress-Induced Cognitive Impairment in Mice | |
| Shigeto Hirayama,Takashi Iwai,Eika Higashi,Minami Nakamura,Chiharu Iwamatsu,Kennosuke Itoh,Toru Nemoto,Mitsuo Tanabe,Hideaki Fujii |
| ACS Chemical Neuroscience.2019;10(5)2237 |
| [DOI] |
|
| 15 | ß-Blockade for Patients with Hypertension, Ischemic Heart Disease or Heart Failure: Where are We Now? | |
| Atul Pathak,Sanaa Mrabeti |
| Vascular Health and Risk Management.2021;Volume 17(5)337 |
| [DOI] |
|
| 16 | The antagonistic activity of H1 receptor antagonists as medicinal foods | |
| Shiyang Zhou,Gangliang Huang,Guangying Chen |
| Trends in Food Science & Technology.2020;105(5)1 |
| [DOI] |
|
| 17 | Classical and novel pharmacological insights offered by the simple chick cardiomyocyte cell culture model: a valuable teaching aid and a primer for “real” research | |
| N. S. Freestone,C. L. S. Sam |
| Advances in Physiology Education.2017;41(1)163 |
| [DOI] |
|
| 18 | Critical role of Aquaporin-1 and telocytes in infantile hemangioma response to propranolol beta blockade | |
| François Moisan,Sandra Oucherif,Priscilla Kaulanjan-Checkmodine,Sorilla Prey,Benoît Rousseau,Marc Bonneu,Stéphane Claverol,Etienne Gontier,Sabrina Lacomme,Lea Dousset,Thierry Couffinhal,Jerome Toutain,Maya Loot,Muriel Cario-André,Marie-Laure Jullié,Christine Léauté-Labrèze,Alain Taieb,Hamid Reza Rezvani |
| Proceedings of the National Academy of Sciences.2021;118(7)163 |
| [DOI] |
|
| 19 | Pimavanserin for the treatment of Parkinson’s disease psychosis | |
| Ines Chendo,Joaquim J Ferreira |
| Expert Opinion on Pharmacotherapy.2016;17(15)2115 |
| [DOI] |
|
| 20 | Preclinical evaluation ofSMM-189, a cannabinoid receptor 2-specific inverse agonist | |
| Chaela Presley,Ammaar Abidi,Satyendra Suryawanshi,Suni Mustafa,Bernd Meibohm,Bob M. Moore |
| Pharmacology Research & Perspectives.2015;3(4)2115 |
| [DOI] |
|
| 21 | Evaluation of oncogenic cysteinyl leukotriene receptor 2 as a therapeutic target for uveal melanoma | |
| K. Slater,P. S. Hoo,A. M. Buckley,J. M. Piulats,A. Villanueva,A. Portela,B. N. Kennedy |
| Cancer and Metastasis Reviews.2018;37(2-3)335 |
| [DOI] |
|
| 22 | Development of tolerance to chemokine receptor antagonists: current paradigms and the need for further investigation | |
| Patrick Grudzien,Henry Neufeld,Mbasogo Ebe Eyenga,Vadim Gaponenko |
| Frontiers in Immunology.2023;14(2-3)335 |
| [DOI] |
|
| 23 | Histamine 2 receptor antagonism elicits protection against doxorubicin-induced cardiotoxicity in rodent model | |
| Sundar Kumar Kondru,Ajay Godwin Potnuri,Lingesh Allakonda,Prasad Konduri |
| Molecular and Cellular Biochemistry.2018;441(1-2)77 |
| [DOI] |
|
| 24 | Beta-blockers in patients with chronic obstructive disease and coexistent cardiac illnesses | |
| Luis Puente-Maestu,Luis Antonio Álvarez-Sala,Javier de Miguel-Díez |
| COPD Research and Practice.2015;1(1)77 |
| [DOI] |
|
| 25 | Beta-blockers in patients with chronic obstructive disease and coexistent cardiac illnesses | |
| Luis Puente-Maestu,Luis Antonio Álvarez-Sala,Javier de Miguel-Díez |
| COPD Research and Practice.2014;1(1)67 |
| [DOI] |
|
| 26 | Adrenal angiotensin II type 1 receptor biased signaling: The case for “biased” inverse agonism for effective aldosterone suppression | |
| Krysten E. Ferraino,Natalie Cora,Celina M. Pollard,Anastasiya Sizova,Jennifer Maning,Anastasios Lymperopoulos |
| Cellular Signalling.2021;82(1)109967 |
| [DOI] |
|
| 27 | Adrenal angiotensin II type 1 receptor biased signaling: The case for “biased” inverse agonism for effective aldosterone suppression | |
| Anastasios Lymperopoulos,Jordana I. Borges,Malka S. Suster |
| Cellular Signalling.2023;82(1)109967 |
| [DOI] |
|
| 28 | Recent Advances in the Drug Discovery and Development of Dualsteric/ Bitopic Activators of G Protein-Coupled Receptors | |
| Bethany A. Reinecke,Huiqun Wang,Yan Zhang |
| Current Topics in Medicinal Chemistry.2019;19(26)2378 |
| [DOI] |
|
| 29 | Allosteric Inhibition of Serotonin 5-HT7 Receptors by Zinc Ions | |
| Grzegorz Satala,Beata Duszynska,Tomasz Lenda,Gabriel Nowak,Andrzej J. Bojarski |
| Molecular Neurobiology.2018;55(4)2897 |
| [DOI] |
|
| 30 | Allosteric Inhibition of Serotonin 5-HT7 Receptors by Zinc Ions | |
| Derek G. Waller,Anthony P. Sampson |
| Molecular Neurobiology.2018;55(4)3 |
| [DOI] |
|
| 31 | Chronic diphenhydramine abuse and withdrawal | |
| Jagroop S. Saran,Richard L. Barbano,Rachel Schult,Timothy J. Wiegand,Olga Selioutski |
| Neurology: Clinical Practice.2017;7(5)439 |
| [DOI] |
|
| 32 | Improving the Propranolol Treatment of Melanoma | |
| Salvatore Patanè |
| JAMA Oncology.2018;4(7)1013 |
| [DOI] |
|
| 33 | Intracellular Peptides in Cell Biology and Pharmacology | |
| Salvatore de Araujo,Salvatore Heimann,Salvatore Remer,Salvatore Russo,Salvatore Colquhoun,Salvatore Forti,Salvatore Ferro |
| Biomolecules.2019;9(4)150 |
| [DOI] |
|
| 34 | Intracellular Peptides in Cell Biology and Pharmacology | |
| Murat Özgören,Adile Öniz |
| Biomolecules.2023;18(4)481 |
| [DOI] |
|
| 35 | Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity | |
| Kelly A Berg,William P Clarke |
| International Journal of Neuropsychopharmacology.2018;21(10)962 |
| [DOI] |
|
| 36 | Na+-mimicking ligands stabilize the inactive state of leukotriene B4 receptor BLT1 | |
| Tetsuya Hori,Toshiaki Okuno,Kunio Hirata,Keitaro Yamashita,Yoshiaki Kawano,Masaki Yamamoto,Masakatsu Hato,Motonao Nakamura,Takao Shimizu,Takehiko Yokomizo,Masashi Miyano,Shigeyuki Yokoyama |
| Nature Chemical Biology.2018;14(3)262 |
| [DOI] |
|
| 37 | Toxicological Evaluation of a Potential Immunosensitizer for Use as a Mucosal Adjuvant—Bacillus thuringiensis Cry1Ac Spore-Crystals: A Possible Inverse Agonist that Deserves Further Investigation | |
| Bélin Mezzomo,Ana Miranda-Vilela,Cesar Grisolia |
| Toxins.2015;7(12)5348 |
| [DOI] |
|
| 38 | Toxicological Evaluation of a Potential Immunosensitizer for Use as a Mucosal Adjuvant—Bacillus thuringiensis Cry1Ac Spore-Crystals: A Possible Inverse Agonist that Deserves Further Investigation | |
| Alfredo Meneses,Rossana Nieto-Vera,Rosa María Anaya-Jiménez |
| Toxins.2018;7(12)259 |
| [DOI] |
|
| 39 | ß-adrenergic Receptor Blocker ICI 118,551 Selectively Increases Intermediate-Conductance Calcium-Activated Potassium Channel (IKCa)-Mediated Relaxations in Rat Main Mesenteric Artery | |
| Melike Hacer Ozkan,Serdar Uma |
| Basic & Clinical Pharmacology & Toxicology.2018;122(6)570 |
| [DOI] |
|
| 40 | Pimavanserin for the treatment of Parkinson's disease psychosis | |
| Joseph H Friedman |
| Expert Opinion on Pharmacotherapy.2013;14(14)1969 |
| [DOI] |
|
| 41 | RETRACTED ARTICLE: ß2-adrenoreceptor Inverse Agonist Down-regulates Muscarine Cholinergic Subtype-3 Receptor and Its Downstream Signal Pathways in Airway Smooth Muscle Cells in vitro | |
| Jian Luo,Yuan-hua Liu,Wei Luo,Zhu Luo,Chun-tao Liu |
| Scientific Reports.2017;7(1)1969 |
| [DOI] |
|
| 42 | Synthesis of anti-allergic drugs | |
| Shiyang Zhou,Gangliang Huang |
| RSC Advances.2020;10(10)5874 |
| [DOI] |
|
| 43 | Potential serotonergic agents for the treatment of schizophrenia | |
| Ricardo P. Garay,Michel Bourin,Evelyne de Paillette,Ludovic Samalin,Ahcène Hameg,Pierre-Michel Llorca |
| Expert Opinion on Investigational Drugs.2016;25(2)159 |
| [DOI] |
|
| 44 | Allergic-like contrast media reaction management in children | |
| Jonathan R. Dillman,Andrew T. Trout,Matthew S. Davenport |
| Pediatric Radiology.2018;48(12)1688 |
| [DOI] |
|
| 45 | Cannabinoid receptor 1 ligands revisited: Pharmacological assessment in the ACTOne system | |
| Chaela S. Presley,Ammaar H. Abidi,Bob M. Moore |
| Analytical Biochemistry.2016;498(12)8 |
| [DOI] |
|
